Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Yohimbe Ban Suggested, 'God' Warned: Health And Wellness Industry News

This article is powered by The Rose Sheet

Executive Summary

ED-spiked supplement importers identified; FDA and FTC act on GAO outreach suggestion; ephedra-like rulemaking needed for yohimbe – study; and God's book among violative claims by Florida firm.

You may also be interested in...



Fructis Products From Mexico, South Korea Aloe Gels On FDA Import Alerts

Benton Korea and Ezekiel Cosmetics each shipped 12 products to the US labeled with claims or ingredients, other than aloe, that render them drugs under FDA regulations. Fructis brand hair care products made by two Mexico firms also were detained due to drug claims

GAO Memory Supplement Review Recalls FDA's Regulatory Challenges

GAO recommends better cooperation between FDA and FTC and more public outreach are key to preventing consumers from believing noncompliant cognitive benefit claims for supplements.

FDA Reaps More Spiked Supplements From International Mail Shipments

FDA identifies 14 products in examinations of international mail shipments found to contain approved and banned drug ingredients indicated for weight loss, erectile dysfunction and depression.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121100

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel